To: Bilberry who wrote (7358 ) 1/31/1999 4:34:00 PM From: STLMD Read Replies (1) | Respond to of 9695
I happen to agree with Bilberry. I am long the JMAR technology and have been accumulating shares in the 1 1/2 to 2 1/2 range for the past three years. I have not overlooked the rest of the market and have invested in fundamentally strong and growing large and small cap stocks. The best analogy for JMAR would not be to Cymer(present day Cymer anyway) or MSFT but with those companies in the biotechnology business who are developing new treatments for medicine and scientific application. Most of these companies have gone nowhere or lower since 1991 as the rush to other stocks, primarily large cap and large technology stocks. Why stay in JMAR. If one has researched the links left by Candlestick, Betty, and Bilberry, one knows that JMAR is developing(keyword remains "developing") niche markets in a wide range of applications, anyone which being successful will launch this company. And to boot, they're profitable, have hired prominent scientists in their respective fields over the past year and "appear" poised to capture an emerging market. According to all public statements that launch pad is grounded in 1999. If no performance then I will sell because of misleading statements by management. I ,however, believe this to continue to be an opportunity for that niche investment market of mine named speculative, emerging, potentially awesome returns. Hardly 30% of my portfolio but a strong 5% of money that has been as good as a CD(my JMAR returns) over the past three years waiting for that launch to occur. Apologies ahead of time but for those naysayers please give me a technology company that wasn't a dog for a long time before it "busted out". Stephen